INBX
Inhibrx Biosciences, Inc.
93.40$
-1.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -17.4% | -6.3% | -10.5% | -13.9% | -18.8% | +34.2% | -12.6% | -16.3% | -17.5% | +25.6% | -16.2% | |
| – | -18.7% | -7.0% | -11.8% | -14.3% | -22.7% | +39.3% | -13.2% | -16.8% | -17.7% | +29.0% | -17.0% | |
| – | -17.6% | -9.2% | -10.1% | -13.5% | -22.3% | +41.9% | -13.8% | -17.9% | -18.9% | +30.1% | -17.5% | |
| – | -17.6% | -9.2% | -10.1% | -13.5% | -22.3% | +41.9% | -13.8% | -17.9% | -18.9% | +30.1% | -17.5% | |
| – | +135.0% | +290.5% | -54.3% | -18.7% | -62.7% | -49.0% | +351.9% | -13.4% | -78.9% | +5.1% | -29.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.7% | +4.8% | -85.9% | +12.9% | +7.0% | +214.1% | -3.1% | -2.0% | -1.5% | +48.0% | +1.1% | |
| – | +57.4% | +27.6% | -45.7% | +12.9% | -7.6% | +7.1% | -10.8% | -7.6% | -6.1% | -21.6% | +5.9% | |
| – | +2.6% | +178.7% | -62.2% | -15.5% | -13.1% | +23.7% | +9.9% | +3.6% | +3.5% | +3.5% | +3.4% | |
| – | +39.4% | +12.9% | +5.3% | -5.0% | -25.3% | -3.8% | -6.7% | -18.3% | -12.2% | +47.4% | +11.8% | |
| – | – | – | – | – | – | – | +0.6% | +0.6% | +0.6% | +74.0% | +0.7% | |
| – | -66.4% | -73.4% | +1,796.3% | -18.6% | -25.1% | -29.3% | -27.4% | -46.3% | -78.3% | -363.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +14.6% | +1.0% | -72.9% | +4.5% | -6.4% | +6.9% | +0.0% | +0.1% | +0.1% | +0.6% | +0.5% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.